Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CLP 257 is a K+/Cl- cotransporter 2 (KCC2) activator.1,2,3 It induces chloride transport in NG108-cl cells that endogenously express low levels of KCC2 (EC50 = 616 nM).1 It is selective for KCC2 over GABAA receptors at 50 µM. CLP 257 (25 µM) increases the rate of chloride accumulation in spinal slices isolated from a rat model of peripheral nerve injury and BDNF control slices, which exhibit reduced levels of KCC2. In vivo, CLP 257 (100 mg/kg) increases mechanical and withdrawal thresholds in a rat model of peripheral nerve injury and reverses morphine-induced hyperalgesia in rats.1,4
WARNING This product is not for human or veterinary use.
1. Chloride extrusion enhancers as novel therapeutics for neurological diseases. Nat. Med. 19(11), 1524-1528 (2013).
2. The small molecule CLP257 does not modify activity of the K+-
3. Reply to The small molecule CLP257 does not modify activity of the K+-
4. Enhancing KCC2 function counteracts morphine-